We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
Cap. Flow
-$2.02B
Cap. Flow %
-2.45%
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 26.12%
2 Consumer Discretionary 15.99%
3 Communication Services 13.72%
4 Healthcare 12.84%
5 Industrials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEI icon
226
HEICO Corp
HEI
$51.4B
$32.4M 0.04%
232,335
+9,085
+4% +$1.25M
LSTR icon
227
Landstar System
LSTR
$6.21B
$32.2M 0.04%
203,967
+24,329
+14% +$4.09M
LBRDK icon
228
Liberty Broadband Class C
LBRDK
$5.15B
$32M 0.04%
184,445
+5,002
+3% +$805K
BR icon
229
Broadridge
BR
$19B
$32M 0.04%
198,229
+7,787
+4% +$1.24M
ACHC icon
230
Acadia Healthcare
ACHC
$2.94B
$31.6M 0.04%
503,532
+84,399
+20% +$5.29M
COLD icon
231
Americold
COLD
$4.27B
$31.6M 0.04%
833,873
+15,191
+2% +$588K
LGF.B
232
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$31.5M 0.04%
1,719,087
+591,674
+52% +$9.07M
MANT
233
DELISTED
Mantech International Corp
MANT
$31.5M 0.04%
363,471
+31,186
+9% +$2.7M
MDRX
234
DELISTED
Veradigm Inc. Common Stock
MDRX
$31.2M 0.04%
1,687,755
+465,444
+38% +$7.83M
HZNP
235
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$31.1M 0.04%
332,235
+12,508
+4% +$1.15M
HXL icon
236
Hexcel
HXL
$7.82B
$30.9M 0.04%
495,760
+166,558
+51% +$9.6M
SMAR
237
DELISTED
Smartsheet Inc.
SMAR
$30.9M 0.04%
427,487
+16,836
+4% +$1.05M
LSXMK
238
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$30.8M 0.04%
856,761
+231,420
+37% +$7.97M
PEGA icon
239
Pegasystems
PEGA
$5.38B
$30.3M 0.04%
435,268
+16,658
+4% +$1.05M
AVLR
240
DELISTED
Avalara, Inc.
AVLR
$30.3M 0.04%
187,198
+7,173
+4% +$1,000K
TYL icon
241
Tyler Technologies
TYL
$12.8B
$30.3M 0.04%
66,949
+2,536
+4% +$1.08M
ADC icon
242
Agree Realty
ADC
$9.41B
$30M 0.04%
425,440
+3,610
+0.9% +$253K
AERI
243
DELISTED
Aerie Pharmaceuticals
AERI
$30M 0.04%
1,872,070
-38,030
-2% -$652K
CIEN icon
244
Ciena
CIEN
$58.4B
$29M 0.04%
+509,438
New +$28.1M
CHGG icon
245
Chegg
CHGG
$102M
$28.6M 0.03%
343,638
+13,369
+4% +$1.11M
AVTR icon
246
Avantor
AVTR
$9.19B
$28.5M 0.03%
802,981
+31,919
+4% +$1.03M
CHUY
247
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$28.5M 0.03%
+764,688
New +$32.5M
TREX icon
248
Trex
TREX
$5.01B
$28.2M 0.03%
275,690
+39,712
+17% +$4.01M
PB icon
249
Prosperity Bancshares
PB
$8.89B
$27.9M 0.03%
389,152
-3,583
-0.9% -$268K
SNX icon
250
TD Synnex
SNX
$20.2B
$27.1M 0.03%
222,226
+6,101
+3% +$750K

Similar funds

Loomis, Sayles & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
  • Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
  • Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
  • Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
  • Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
  • Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.